DataSheet_1_Including Volume Effects in Biological Treatment Plan Optimization for Carbon Ion Therapy: Generalized Equivalent Uniform Dose-Based Objective in TRiP98.pdf by Marco Battestini (12268814)

“…The multi-field optimization problem here takes also into account the relative biological effectiveness (RBE), which in the case of ion beams is not factorizable and introduces strong non-linearity. We implemented the gEUD-based optimization in TRiP98, allowing us to control the whole dose–volume histogram (DVH) shape of OAR with a single objective by adjusting the prescribed gEUD₀ and the volume effect parameter a, reducing the volume receiving dose levels close to mean dose when a = 1 (large volume effect) while close to maximum dose for a >> 1 (small volume effect), depending on the organ type considered. …”

Barnes maze testing in animals on post-injury day 1. by Ghaith A. Bahader (21387572)

“…(A) Briefly, animals received acclimation and then four days of acquisition with expected decreasing mean times to escape. …”

Mitochondria from immature and mature Mks subjected to shear flow have different levels of intact cytochrome c. by Stephanie A. Luff (5770898)

“…A peak shift to the left demonstrates decreased cytochrome c in the mitochondria membrane. …”

Downstream cascade was further explored and it was shown that hypobaric hypoxia reduces GSK3ß phosphorylation (A) and hence its inactivation whereas enriched environment significan... by Vishal Jain (14349)

“…Moreover hypobaric hypoxia also decreases the CREB phosphorylation (B) whereas exposing them with enriched environment normalizes this decreased level of CREB phosphorylation. …”

Sources of error and effects of error correction in ccfDNA. by David A. Nix (8033303)

“…Accounting for all of the different sources of noise yielded the lowest error (<b>d</b>, pink), which continually decreased with increments in family size. Data points shown in (<b>d</b>) represent the mean value from the seven control samples. …”

Non-monotonic induction of <i>icl1</i>. by Joao A. Ascensao (2273545)

“…<p>(A) Structure of <i>icl1</i> transcriptional regulation network. …”

R₀ sensitivity analysis. by Victor A. Meszaros (7207760)

“…White bars indicate the value of <i>R</i>₀ when the associated parameter is <i>decreased</i> by 25%. <b>Right</b>: A Partial Rank Correlation Coefficient (PRCC) analysis was preformed with respect to <i>R</i>₀ highlighting the inter-correlated sensitivities of each of the model parameters. …”

Evaluation of novel 3-D invasion assay. by Nikki A. Evensen (495977)

“…An invasive growth pattern was photographed on day 1 (A) and day 6 (B) respectively. TIMP-2 and the anti-PEX Ab decreased the cell invasive/scattering ability of MT1-GFP expressing cells. …”

Flow cytometry analysis of candidate deletion strains. by Ramsey A. Saleem (244511)

“…BY4741 is used as a non-fluorescent control strain.</p>…”

Effects of the NM-2 inhibitor blebbistatin on fusion pore kinetics in mast cells. by Juan A. Flores (587973)

“…C_v, vesicle capacitance (C). A fusion pore analysis demonstrated that treatment with 5 µM blebbistatin decreased the fusion pore conductance Gp (D) and increased the fusion pore duration (E) (control: n = 35 pores; blebbistatin: n = 30 pores). …”

Regeneration-associated cells increased post-QQ culturing. by Amankeldi A. Salybekov (6018689)

“…<b>(D)</b> The number of total T lymphocytes and <b>(E)</b> cytotoxic T CD8+ lymphocytes, significantly decreased in QQ cultured cells. (<b>A-E</b> n = 6 rats per group<b>) (F</b>) Relative gene expression profile of QQMNCs compared to PBMNCs (n = 5 rats per group, red bar is upregulated, and blue bar is downregulated, all values are log transformed). …”

Multi-way sensitivity analysis of patient cost, healthcare system cost, drug formulation availability, and effectiveness. by Brandon A. Berger (3909634)

“…A diamond at the origin represents the mean case as calculated by the Monte Carlo model. …”

Modulation of Bcl-xL expression is required for apoptotic effects of CLPTM1L. by Michael A. James (160308)

“…<p>A) Western blotting for apoptotic regulators in A549 cells with CLPTM1L knockdown after treatment with cisplatin showing decreased Bcl-xL expression upon loss of CLPTM1L. …”

Effects of the NM-2 inhibitor blebbistatin on fusion pore kinetics in mast cells. by Juan A. Flores (587973)

“…C_v, vesicle capacitance (C). A fusion pore analysis demonstrated that treatment with 5 µM blebbistatin decreased the fusion pore conductance Gp (D) and increased the fusion pore duration (E) (control: n = 35 pores; blebbistatin: n = 30 pores). …”

Expression and phosphorylation of TIE2 in mice after LPS. by Jose A. Adams (624746)

“…LPS did not significantly change expression of TIE2, but significantly decreased TIE2 phosphorylation. <b>(A)</b> pGz pre-treatment (pGz-LPS) and <b>(B)</b> pGz post-treatment (LPS-pGz) significantly increased both TIE2 expression and phosphorylation. …”

Role of NOS isoforms in VEGF overexpressed lung cell proliferation. by Mansoor A. Syed (847484)

“…Each bar represents the mean ± SEM for a minimum of three animals. *<i>P</i> < 0.05, **<i>P</i> ≤ 0.01, and ****<i>P</i> ≤ 0.0001, 2-way ANOVA followed by Tukey test. …”

DataSheet1_Studying C-reactive protein and D-dimer levels in blood may prevent severe complications: A study in Bangladeshi COVID-19 patients.PDF by Gazi Nurun Nahar Sultana (9419582)

Association between post-transplant serum uric acid levels and kidney transplantation outcomes by Deok Gie Kim (6086909)

“…</p><p>Objective</p><p>This study aimed to investigate the effect of mean serum UA level during two different post-KT periods on long-term renal graft outcomes in a large population cohort in which living donor KT prevails.…”

Western blot analysis of phospho-Akt protein (A), HO-1 protein (B), Nrf2 total (C) and nucleoprotein (D) expressions in the renal tissue of six groups. by Jian-bo Yu (614041)

Effect of VEGF overexpression on cathepsins L and H mRNA expression in the BPD murine model. by Mansoor A. Syed (847484)

“…Each bar represents the mean ± SEM for a minimum of four animals. **<i>P</i> ≤ 0.01 and ***<i>P</i> ≤ 0.001, 2-way ANOVA followed by Tukey test. …”